| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Bexotegrast | PLN-74809 | Phase 3 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | Details |
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis | Details |
| Nesvategrast | OTT-166(OcuTerra Therapeutics); SF-0166 | Phase 2 Clinical | Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc | Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration | Details |
| 18F-αvβ6-Binding-Peptide | 18F-αvβ6-BP | Phase 1 Clinical | National Cancer Institute, National Institutes Of Health | Rectal Neoplasms; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Metastatic breast cancer | Details |
| [18F]FP-R01-MG | [18F]FP-R01-MG; [18F]FP-R01-MG-F2 | Phase 1 Clinical | Pliant Therapeutics Inc, Stanford University, Chinese Academy Of Medical Science & Peking Union Medical College | Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Cholangitis, Sclerosing; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Ga-68-Trivehexin | RAD-301 | Phase 1 Clinical | Trimt GmbH | Pancreatic Neoplasms; Carcinoma, Pancreatic Ductal | Details |